<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) become dependent on blood transfusions and develop into transfusional <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e>, which is exacerbated by increased absorption of dietary iron in response to <z:hpo ids='HP_0010972'>ineffective erythropoiesis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, it is uncertain whether there is an association among iron accumulation, clinical complications, and decreased likelihood of survival in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>Thereby our current understanding of the effects of transfusion dependency and <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> are discussed </plain></SENT>
<SENT sid="3" pm="."><plain>Particular emphasis should be placed on further characterizing the role of redox-active forms of labile iron and <z:mp ids='MP_0003674'>oxidative stress</z:mp> in <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e>, decreased life expectancy and increased risk of leukemic transformation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> </plain></SENT>
</text></document>